Literature DB >> 15940668

Association of CTLA4 polymorphism with regulatory T cell frequency.

Sowsan F Atabani1, Chloe L Thio, Senad Divanovic, Aurelien Trompette, Yasmine Belkaid, David L Thomas, Christopher L Karp.   

Abstract

A common single nucleotide polymorphism in CTLA4 has been linked with susceptibility and outcome in autoimmune and infectious diseases, respectively. Here, we show that this polymorphism is associated with the frequency of CD4(+)CD25(+) regulatory T cells in healthy human volunteers. We further show that, on a per cell basis, such regulatory T cells appear to be functionally indistinguishable across CTLA4 genotypes. These data implicate CTLA4 in regulatory T cell development, and provide a mechanism to account for the link between polymorphisms at this locus and the biological outcome of adaptive immune responses to self and to pathogens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15940668     DOI: 10.1002/eji.200526168

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  33 in total

Review 1.  Historical overview of immunological tolerance.

Authors:  Ronald H Schwartz
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

2.  The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children.

Authors:  C-O Jonson; M Hedman; M Karlsson Faresjö; R Casas; J Ilonen; J Ludvigsson; O Vaarala
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

3.  An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.

Authors:  Abdeljabar El Andaloussi; Maciej S Lesniak
Journal:  Neuro Oncol       Date:  2006-05-24       Impact factor: 12.300

Review 4.  Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.

Authors:  Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 5.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 6.  Autologous regulatory T cells for the treatment of type 1 diabetes.

Authors:  James A Thompson; Daniel Perry; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

7.  CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques.

Authors:  Anna Hryniewicz; Adriano Boasso; Yvette Edghill-Smith; Monica Vaccari; Dietmar Fuchs; David Venzon; Janos Nacsa; Michael R Betts; Wen-Po Tsai; Jean-Michel Heraud; Brigitte Beer; Diann Blanset; Claire Chougnet; Israel Lowy; Gene M Shearer; Genoveffa Franchini
Journal:  Blood       Date:  2006-08-08       Impact factor: 22.113

8.  Variation in the CTLA4 3'UTR has phenotypic consequences for autoreactive T cells and associates with genetic risk for type 1 diabetes.

Authors:  V M de Jong; A Zaldumbide; A R van der Slik; S Laban; B P C Koeleman; B O Roep
Journal:  Genes Immun       Date:  2015-12-10       Impact factor: 2.676

9.  CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer.

Authors:  Marleen M Welsh; Katie M Applebaum; Steven K Spencer; Ann E Perry; Margaret R Karagas; Heather H Nelson
Journal:  Cancer Res       Date:  2009-07-21       Impact factor: 12.701

10.  Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells.

Authors:  Jun Yamanouchi; Maria-Carmen Puertas; Joan Verdaguer; Paul A Lyons; Daniel B Rainbow; Giselle Chamberlain; Kara M Hunter; Laurence B Peterson; Linda S Wicker; Pere Santamaria
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.